2Invest AG
XETRA:2INV
2Invest AG
XETRA:2INV
Price:
11.4
EUR
Market Closed
Market Cap:
€65.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Popular Picks
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
2Invest AG
Cash from Investing Activities
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
2Invest AG
Cash from Investing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
2Invest AG
XETRA:2INV
|
Cash from Investing Activities
€20.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
70%
|
CAGR 10-Years
N/A
|
|
|
BioNTech SE
NASDAQ:BNTX
|
Cash from Investing Activities
-€2.5B
|
CAGR 3-Years
-313%
|
CAGR 5-Years
-76%
|
CAGR 10-Years
N/A
|
|
|
CureVac NV
NASDAQ:CVAC
|
Cash from Investing Activities
-€18.4m
|
CAGR 3-Years
48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Immatics NV
NASDAQ:IMTX
|
Cash from Investing Activities
€204.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Immunic Inc
NASDAQ:IMUX
|
Cash from Investing Activities
-$161k
|
CAGR 3-Years
75%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
19%
|
|
|
Biotest AG
XETRA:BIO
|
Cash from Investing Activities
-€16.9m
|
CAGR 3-Years
14%
|
CAGR 5-Years
-50%
|
CAGR 10-Years
19%
|
|
No Stocks Found
2Invest AG
Glance View
2invest AG is a holding company, which engages in life sciences field and is primarily active in the areas of immunology, proteomics and genomics. The company is headquartered in Heidelberg, Baden-Wuerttemberg and currently employs 2 full-time employees. The company went IPO on 2000-08-10. 2invest AG acquires, holds, manages and sells investments in corporations and partnership in the biotechnology, life science and information technologies (IT) sectors in Germany and abroad.
2INV
Intrinsic Value
74.41
EUR
Undervaluation 85%
See Also
What is 2Invest AG's Cash from Investing Activities?
Cash from Investing Activities
20.9m
EUR
20.9m
EUR
Based on the financial report for Dec 31, 2024, 2Invest AG's Cash from Investing Activities amounts to 20.9m EUR.
What is 2Invest AG's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
70%
70%
